pharmaceutical investing Algernon Submits for Ethics Approval in Australia for Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
pharmaceutical investing Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia
pharmaceutical investing Algernon Pharmaceuticals Announces up to $5.0 Million Private Placement Offering of Special Warrants
Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
pharmaceutical investing Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD
pharmaceutical investing Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
pharmaceutical investing Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
pharmaceutical investing Algernon Receives Positive Feedback from U.S. FDA for New Ifenprodil Intravenous Formulation
pharmaceutical investing Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board
pharmaceutical investing Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea
pharmaceutical investing Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial
pharmaceutical investing Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19
pharmaceutical investing Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study
pharmaceutical investing Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19
80 Mile PLC Secures 3 Strategic MOUs with Fortune 500 Energy Group, Ludoil, and JEnergy and moves to 100% of Ferrandina Biofuels Plant
Cotec Purchases Commercial Scale Salter Cyclone Multi-Gravity-Separator Unit to be Located at Corem Québec, Canada
TSX-V: TT Closes Acquisition of High Lake and West Hawk Lake from McFarlane Lake Mining and Closing of Final Tranche of Non-Brokered Private Placement
Element One Hydrogen and Critical Minerals Announces Letter of Intent to Acquire Hydrogen and Critical Mineral Extraction Technology
